Holen Sie sich die Stockscreener-App
32.18
0.27%
0.14
Schlusskurs vom Vortag:
$32.04
Offen:
$31.82
24-Stunden-Volumen:
134.74K
Relative Volume:
0.35
Marktkapitalisierung:
$1.01B
Einnahmen:
$566.77M
Nettoeinkommen (Verlust:
$48.16M
KGV:
27.04
EPS:
1.19
Netto-Cashflow:
$274.29M
1W Leistung:
-3.79%
1M Leistung:
-13.92%
6M Leistung:
+20.18%
1J Leistung:
-15.46%
1-Tages-Spanne:
$31.59
$32.36
1-Wochen-Bereich:
$31.26
$33.91
52-Wochen-Spanne:
$23.23
$39.95
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Firmenname
Collegium Pharmaceutical Inc
Sektor
Telefon
781-713-3699
Adresse
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Vergleichen Sie COLL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
32.13 | 1.01B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
143.45 | 63.05B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.79 | 43.33B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.17 | 40.43B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.12 | 22.97B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
432.85 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | Needham | Hold → Buy |
| 2024-07-30 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Hochstufung | Jefferies | Hold → Buy |
| 2024-05-10 | Herabstufung | Needham | Buy → Hold |
| 2024-05-10 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-08-25 | Bestätigt | Needham | Buy |
| 2023-05-02 | Fortgesetzt | Jefferies | Buy |
| 2022-08-08 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-14 | Eingeleitet | BWS Financial | Sell |
| 2020-05-27 | Eingeleitet | Guggenheim | Neutral |
| 2020-02-19 | Fortgesetzt | Jefferies | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-05-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2019-04-12 | Fortgesetzt | Janney | Buy |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-01-16 | Bestätigt | Needham | Buy |
| 2018-03-08 | Bestätigt | H.C. Wainwright | Buy |
| 2018-02-07 | Bestätigt | Needham | Buy |
| 2017-12-05 | Bestätigt | Needham | Buy |
| 2017-09-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-05-11 | Bestätigt | Needham | Buy |
| 2016-09-13 | Eingeleitet | Gabelli & Co | Buy |
| 2015-06-01 | Eingeleitet | Jefferies | Buy |
| 2015-06-01 | Eingeleitet | Needham | Buy |
| 2015-06-01 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Collegium Pharmaceutical Inc Aktie (COLL) Neueste Nachrichten
Collegium Pharmaceutical Inc. Rings the Opening Bell - Nasdaq
Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing - Sahm
Strategies to average down on Collegium Pharmaceutical Inc.July 2025 Fed Impact & Community Shared Stock Ideas - newser.com
How Collegium Pharmaceutical Inc. (354) stock compares with tech leadersPortfolio Value Summary & Weekly Market Pulse Updates - newser.com
Will Collegium Pharmaceutical Inc. stock gain from strong economyWeekly Trading Summary & Consistent Return Investment Signals - newser.com
Why retail investors pile into Collegium Pharmaceutical Inc. stock2025 Market Outlook & Momentum Based Trading Signals - newser.com
Is Collegium Pharmaceutical Inc. stock a top pick in earnings seasonWeekly Market Report & Low Risk Entry Point Guides - newser.com
How interest rate cuts could boost Collegium Pharmaceutical Inc. stockGlobal Markets & High Accuracy Buy Signal Tips - newser.com
10-Year Anniversary: Collegium to Ring Nasdaq Bell Oct. 14, 2025; Highlights Jornay PM ADHD growth - Stock Titan
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates - sharewise.com
Collegium Pharmaceutical Experiences Revision in Its Stock Evaluation Amidst Market Dynamics - Markets Mojo
UnitedHealth, Brookdale, Collegium Pharmaceutical, QuidelOrtho, and Biogen Shares Are Falling, What You Need To Know - Yahoo Finance
Collegium Pharmaceutical, Inc. (COLL): A Bull Case Theory - MSN
Collegium Pharmaceutical (NASDAQ:COLL) Receives "Hold (C)" Rating from Weiss Ratings - MarketBeat
Pattern recognition hints at Collegium Pharmaceutical Inc. upsideJobs Report & Free Technical Pattern Based Buy Signals - newser.com
Applying sector rotation models to Collegium Pharmaceutical Inc.July 2025 Highlights & Low Risk Investment Opportunities - newser.com
Oversold Conditions For Collegium Pharmaceutical (COLL) - Nasdaq
Chronic Lower Back Pain Market Projected to Grow by 2034 | Eli Lilly, Collegium Pharmaceutical, Purdue Pharma, BioDelivery Sciences, Camurus, Braeburn, Scilex Holding, Mesoblast, AnGes MG, Kolon Life - Barchart.com
Can Collegium Pharmaceutical Inc. rally from current levelsPortfolio Gains Summary & Daily Price Action Insights - newser.com
Is Collegium Pharmaceutical Inc. (354) stock inflation resilientJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - newser.com
Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $42.33 Average Price Target from Brokerages - Defense World
Will Collegium Pharmaceutical Inc. bounce back from current supportWeekly Loss Report & Verified Momentum Stock Ideas - newser.com
Historical volatility pattern of Collegium Pharmaceutical Inc. visualized2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com
Long term hold vs stop loss in Collegium Pharmaceutical Inc.Weekly Risk Summary & AI Powered Market Trend Analysis - newser.com
GAMMA Investing LLC Raises Stake in Collegium Pharmaceutical, Inc. $COLL - Defense World
Will Collegium Pharmaceutical Inc. (354) stock sustain dividend payoutsGap Down & AI Powered Trade Plan Recommendations - newser.com
What drives Collegium Pharmaceutical Inc 354 stock priceEarnings Per Share Trends & High Profit Market Tips - earlytimes.in
Does Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Create Value For Shareholders? - Yahoo Finance
Collegium Pharmaceutical Inc Stock Analysis and ForecastPrice-to-Book Ratio Updates & Free Exceptional Risk Adjusted Gains - earlytimes.in
Collegium Pharmaceutical Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
2.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):